12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Company News  |  Other News

Impax, Shire neurology news

Shire and Impax settled litigation relating to a 2009 deal under which Shire supplies Impax with authorized generic versions of Shire's ADHD drug Adderall XR dextroamphetamine/amphetamine. In 2010, Impax...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >